12:53 · 22 October 2026

US100 drops 1.8% 🚨

Nasdaq-100 futures plunged nearly 1.8% on Thursday, with the US100 falling to 29,467 points (-554 points, -1.85%), as investors once again focused on the “cost” of investing in artificial intelligence. Although Meta beat revenue forecasts (up 26% to $64.6 billion) and SpaceX reported its first profit as a public company, optimism had already evaporated in Asia. The market focused on the costs of AI investments—Meta’s plan to issue Class C shares reignited concerns about the scale of its capital commitments, and Lam Research’s weak outlook sent the company down more than 8% after the close. Tesla is down about 5% in premarket trading, and the chip sector is retreating across the board (Intel and Marvell down more than 5%, Nvidia down 2.2%).

The macroeconomic backdrop isn’t helping: Brent crude is up more than 2% to around $108 following further Houthi attacks on Saudi Arabia, while U.S. 10-year Treasury yields are falling to about 5.09%. In France, the situation looks worse, as yields on 10-year OATs are already rising to 5.05%, widening the spread against German bonds.

Technical Analysis (US100, daily timeframe)

 

The price fell below the EMA100 (29,526) today, which had served as dynamic support over the past few weeks—this is the first sign of a weakening in the short-term trend. The key support zone is around 29,000–29,300 points (the highlighted support rectangle coinciding with the volume profile and the September lows); whether this level holds will determine whether we are dealing merely with a correction within an uptrend. Below this level, the path opens up to the EMA200 at 28,314 points, which is the structural defense line for the entire rally since April.

The RSI (14), currently at 39, is moving toward the oversold zone but has not yet reached extreme levels—this leaves room for the downtrend to continue before a technical rebound occurs. 

 

Market breadth reflects caution: only 56% of Nasdaq-100 companies are trading above their 50-day moving average, and the index’s gap from the 200-day EMA has narrowed to +6.2%—a far cry from earlier, overheated levels. Source: XTB

 

The Nasdaq-100 forward P/E ratio has fallen to 21.9x (below the 126-day average of 23.7x), which somewhat tempers the argument that the market is extremely overvalued; however, in the current environment, it is the valuation of future earnings growth—not multiples—that may determine the direction of the stock market. Source: XTB

9 November 2026, 22:40

Daily Summary: From Panic to Euphoria. The Market Recoups Losses.

9 November 2026, 18:57

US OPEN: Falling Oil Prices and Dip-Buying Fuel Rebound as Nvidia falls

9 November 2026, 17:22

Nvidia’s Problems: A CEO's Scandal and Competitors Breathing Down Its Neck

9 November 2026, 16:53

Market Wrap: Strong Banking Sector, Sharp Drop in Oil

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.